GB virus C/hepatitis G virus - Its role in human disease redefined?

Indian Journal of Medical Research

Volumn 125, Issue 6, 2007, Pages 717-719

  Abraham, Priya ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS ANTIBODY; VIRUS RNA;

DRUG SAFETY; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS G; HEPATITIS G VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; NONHUMAN; NOTE; PHYLOGENY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; RNA ANALYSIS; SEQUENCE HOMOLOGY; SUPERINFECTION; SURVIVAL TIME; UNSPECIFIED SIDE EFFECT; VERTICAL TRANSMISSION; VIREMIA; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; GB VIRUS C; HEPATITIS; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; PHYLOGENY; SPECIES SPECIFICITY; VIRUS DISEASES;

EID: 34548429555     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Note

References (35)

1. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995; 92: 3401-5.
2. Linnen J, Wages Jr. J, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-8.
3. Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 1996; 334: 1536-7.
4. Thomas DL, Vlahov D, Alter HJ, Hunt JC, Marshall R, Astemborski J, et al. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 1998; 177: 539-42.
5. Wong P-Y, Coghlan PJ, Angus PW. Should we be screening blood donors for hepatitis G virus? The case against screening. Med J Aust 1998; 169: 375-7.
6. El-Zayadi AR, Abe K, Selini O, Naito H, Hess G, Ahdy A. Prevalenee of GBV-C/hepatitis G virus viraemia among blood donors, health care personnel, chronic non-B non-C hepatitis, chronic hepatitis C and haemodialysis patients in Egypt. J Virol Methods 1999; 80: 53-8.
7. Kumar D, Gupta RK, Anand R, Pasha ST, Rai A, Das BC, et al. Occurrence and nucleotide sequence analysis of hepatitis G virus in the patients with acute viral hepatitis and fulminant hepatitis. Indian J Med Res 2007; 125: 752-5.
8. Abraham P, Radhakrishnan S, Raghuraman S, Viswanathan T, Daniel D, Sitaram U, et al. GB virus-C/hepatitis G virus and transfusion transmitted virus infection in blood donors in a tertiary care hospital in south India (letter). Vox Sang 2001; 81: 264-5.
9. Panigrahi AK, Saxena A, Acharya SK, Panda SK. Hepatitis G virus in multitransfused thalasssaemics from India. J Gastroenterol Hepatol 1998; 13: 902-6.
10. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB Virus C in patients on maintenance haemodialysis. N Engl J Med 1996; 334 1485-90.
11. Scallan MF, Clutterbuck D, Jarvis LM, Scott GR, Simmonds P. Sexual transmission of GB virus C/hepatitis G virus. J Med Virol 1998; 55: 203-8.
12. Zanetti AR, Tanzi E, Romano L, Principi N, Zuin G, Minola E, et al. Multicenter trial on mother-to-infant transmission of GBV-C virus. J Med Virol 1998; 54: 107-12
13. Kao JH, Liu CJ, Chen PJ, Chen W, Hsiang SC, Lai MY, et al. Interspousal transmission of GB virus C/hepatitis G virus: a comparison with hepatitis C virus. J Med Virol 1997; 53 348-53.
14. Seifried C, Weber M, Bialleck H, Seifried E, Schrezenmeier H, Roth WK. High prevalence of GBV-C/HGV among relatives of GBV-C/HGV positive blood donors in blood recipients and in patients with aplastic anemia. Transfusion 2004; 44: 268-74.
15. Smith DB, Cuceanu N, Davidson F, Jarvis LM, Mokili JLK, Hamid S, et al. Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5′ non-coding region. J Gen Virol 1997 78: 1533-42.
16. Tucker TJ, Smuts HEM. GBV-C/HGV genotypes: Proposed nomenclature for genotypes 1-5. J Med Virol 2000; 62: 82-3.
17. Abraham P, Hallett R, Radhakrishnan S, Raghuraman S, Sridharan G, Teo CG. Hepatitis G virus genotypes in a tertiary care centre in southern India. J Clin Virol 2002; 25: 187-92.
18. Alter HJ. G-pers creepers, where did you get those papers? A re-assessment of the literature on the hepatitis G virus. Transfusion 1997; 7: 569-72.
19. Frider B, Sookoian S, Castano G, Gonzalez J, Flichman D, Viudez P, et al. Detection of hepatitis G virus RNA in patients with acute non-A-E hepatitis. J Viral Hepat 1998; 5: 161-4.
20. Heringlake S, Osterkamp S, Trautwein C, Tillman HL, Boker K, Muerhoff S, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996; 348 1626-9.
21. Wu JC, Chiang TY, Huang YH, Huo TI, Hwang SJ, Huang IS, et al. Prevalence, implication, and viral nucleotide sequence analysis of GB virus-C/hepatitis G virus infection in acute fulminant and nonfulminant hepatitis. J Med Virol 1998; 56: 118-22.
22. Laras A, Zacharakis G, Hadziyannis SJ. Absence of the negative strand of GBV-C/HGV RNA from the liver. J Hepatol 1999; 30: 383-8.
23. Tucker TJ, Smuts HEM, Eedes C, Knobel GD, Eickhaus P, Robson SC, et al. Evidence that the GBV-C/hepatitis G virus is primarily a lymphotropic virus. J Med Virol 2000; 61: 52-8.
24. Dickens T, Lemon SM. GB virus C, hepatitis G virus, or human orphan flavivirus? Hepatology 1997; 25: 1285-6.
25. Miyakawa Y, Mayumi M. Hepatitis G virus - a true hepatitis virus or an accidental tourist? N Engl J Med 1997; 336: 795-6.
26. Okuda K. Is GBV-C (hepatitis G virus) an innocent bystander? J Gastroenterol Hepatol 1998; 13: 763-6.
27. Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H. Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 209-13.
28. Lefrere JJ, Roudot-Thoraval F, Morand-Joubert L, Petit JC, Lerable J, Thauvin M, et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immuhologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 1999; 179 783-9.
29. Yeo AET, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Ann Intern Med 2000; 132: 959-63.
30. Stapleton JT, Williams CF, Xiang J. GB virus type C: a beneficial infection? J Clin Microbiol 2004; 42: 3915-9.
31. Rodriguez B, Woolley I, Lederman MM, Zdunek D, Hess G, Valdez H. Effect of GB virus C co-infection on response to anti-retroviral treatment in human immunodeficiency virus-infected patients. J Infect Dis 2003; 187: 504-7.
32. Weintrob AC, Hamilton JD, Hahn C, Klinzman G, Moyo D, Zdunek G, et al. Active or prior GB virus C infection does not protect against vertical transmission of HIV in co-infected women from Tanzania. Clin Infect Dis 2004; 38: e46-e48. Online. http://www.journals.uchicago.edu/CID/journal/issues/v38n6/32236/ 32236.html.
33. Birk M, Lindback S, Lidman C. No influence of GB virus C replication on the prognosis in a cohort of HIV-1- infected patients. AIDS 2002; 16: 2482-5.
34. Brumme ZL, Chan KJ, Dong WWY, Mo T, Wynhoven B, Hogg RS, et al. No association between GB virus-C viremia and virological or immunological failure after starting initial anti-retroviral therapy. AIDS 2002; 16: 1929-33.
35. Bjorkman P, Flamholc L, Naucler A, Molnegren V, Wallmark E, Widell A. GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS 2004; 18: 877-86.